A Colorado board voted to move forward with setting a price ceiling on the arthritis drug Enbrel on Friday, a first-in-the-nation step that raises questions about whether a single state can reduce ...
When Pfizer’s US Enbrel sales force gives way to Amgen’s in July, reps risk layoff if they don’t get picked up by Amgen or re-assigned to Pfizer’s new JAK inhibitor. The news that Pfizer was turning ...
An appeals court ruling means biosimilar competition won't affect U.S. Enbrel sales for a long time. Enbrel is a tumor necrosis factor (TNF) inhibitor that earned its first FDA approval all the way ...
A state board in Colorado is working to make history by becoming the first in the country to cap the price of a drug it deems unaffordable. Amid an aggressive industry lobbying campaign, Colorado ...
Getting your Trinity Audio player ready... A Colorado board voted unanimously Friday to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted ...
Americans with psoriasis and rheumatoid arthritis will have to wait much longer for low-priced copycat versions of their weekly Enbrel injections. Amgen (NASDAQ: AMGN) won an appeals court ruling on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback